Aldose reductase (AKR1B1), the first rate-limiting enzyme involved in the polyol pathway, is linked to the pathogenesis of diabetes-related issues like cataracts, neuropathy, retinopathy and nephropathy (Kato et al., 2009). Here, AKR1B1 is linked to kidney disorder.